Eunice Kennedy Shrive National Institute of Child Health and Human Development; Notice of Committee Establishment, 14520 [2017-05486]

Download as PDF 14520 Federal Register / Vol. 82, No. 53 / Tuesday, March 21, 2017 / Notices submit an annual report for devices distributed under the custom device exemption. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Annual reporting for custom devices ................................... 33 1 33 40 1,320 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: March 15, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–05349 Filed 3–20–17; 8:45 am] BILLING CODE 4164–01–P Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or spaethj@od.nih.gov. [FR Doc. 2017–05487 Filed 3–20–17; 8:45 am] Dated: March 13, 2017. Leslie Kux, Associate Commissioner for Policy. Dated: March 15, 2017. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK3G9T082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Mental Health Services Research Conflicts. Date: April 7, 2017. Time: 12:00 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Karen Gavin-Evans, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center, 6001 Executive Boulevard, Room 6153, MSC 9606, Bethesda, MD 20892, 301–451–2356, gavinevanskm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) 16:47 Mar 20, 2017 Jkt 241001 BILLING CODE 4140–01–P National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting VerDate Sep<11>2014 [FR Doc. 2017–05486 Filed 3–20–17; 8:45 am] Eunice Kennedy Shrive National Institute of Child Health and Human Development; Notice of Committee Establishment DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. App.), the Director, National Institutes of Health (NIH), announces the establishment of the Task Force on Research Specific to Pregnant Women and Lactating Women (Task Force) as required by section 2041 of the 21st Century Cures Act, Public Law 114–255. The Task Force will provide advice and guidance to the Secretary, Department of Health and Human Services (Secretary), regarding Federal activities related to identifying and addressing gaps in knowledge and research regarding safe and effective therapies for pregnant women and lactating women, including the development of such therapies and the collaboration on and coordination of such activities. The Task Force will, not later than 18 months after the establishment, prepare and submit a report to the Secretary, the Committee on Health, Education, Labor and Pensions of the Senate, and the Committee on Energy and Commerce of the House of Representatives. It is determined that the Task Force is in the public interest in connection with the performance of duties imposed on the NIH by statute, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 National Institutes of Health The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on April 26–27, 2017. The topic for this meeting will be ‘‘Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.’’ The meeting is open to the public. Non-federal individuals planning to attend the workshop should register by email to Charlemae Clarke, The Scientific Consulting Group, Inc. (cclarke@scgcorp.com; please put ‘‘Registration DMICC T1D Meeting’’ in the subject line) at least 7 days prior to the workshop. DATES: The meeting will be held on April 26, 2017 from 8:00 a.m. to 5:45 p.m. and on April 27, 2017 from 8:00 a.m. to 3:00 p.m. ADDRESSES: The meeting will be held in the Conference Room (terrace level) at 5635 Fishers Ln., Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: An agenda for the DMICC meeting will be available by contacting Charlemae Clarke, The Scientific Consulting Group, Inc. (cclarke@scgcorp.com; please put ‘‘Agenda Request for DMICC T1D Meeting’’ in the subject line). For further information concerning this meeting, contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and SUMMARY: E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 82, Number 53 (Tuesday, March 21, 2017)]
[Notices]
[Page 14520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05486]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shrive National Institute of Child Health and 
Human Development; Notice of Committee Establishment

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. App.), the Director, National Institutes of Health (NIH), 
announces the establishment of the Task Force on Research Specific to 
Pregnant Women and Lactating Women (Task Force) as required by section 
2041 of the 21st Century Cures Act, Public Law 114-255.
    The Task Force will provide advice and guidance to the Secretary, 
Department of Health and Human Services (Secretary), regarding Federal 
activities related to identifying and addressing gaps in knowledge and 
research regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities. The Task Force 
will, not later than 18 months after the establishment, prepare and 
submit a report to the Secretary, the Committee on Health, Education, 
Labor and Pensions of the Senate, and the Committee on Energy and 
Commerce of the House of Representatives.
    It is determined that the Task Force is in the public interest in 
connection with the performance of duties imposed on the NIH by 
statute, and that these duties can best be performed through the advice 
and counsel of this group.
    Inquiries may be directed to Jennifer Spaeth, Director, Office of 
Federal Advisory Committee Policy, Office of the Director, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or 
spaethj@od.nih.gov.

    Dated: March 15, 2017.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-05486 Filed 3-20-17; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.